Read/Search this Article
Abstract
We have already reported unique compounds containing a N,O-spiro acetal structure as an orally active factor Xa (FXa) inhibitor. This time, we described a N,N-spiro acetal structure as an analogue of the N,O-spiro acetal structure for an orally active FXa inhibitor. The synthesis of these analogues could be achieved in a similar fashion to the N,O-spiro acetal synthesis. Consequently, FXa inhibitory activity was increased and more active compounds could be found (M58163: IC_<50>=0.61nM, M58169: IC_<50>=0.58nM). Additionally, the absolute configuration could be determined by X-ray crystallography analysis (M58169: (R)-config.).
Journal
- Chemical & pharmaceutical bulletin [List of Volumes]
-
Chemical & pharmaceutical bulletin 54(11), 1535-1544, 2006-11-01 [Table of Contents]
The Pharmaceutical Society of Japan